Pfizer, Roche and GSK report 2009 results
In a busy week of Big Phama results Pfizer reports sales boost from Wyeth, Roche says Genentech hit profits and GSK unveils surge in Relenza sales and plans to expand R&D restructuring.
In a busy week of Big Phama results Pfizer reports sales boost from Wyeth, Roche says Genentech hit profits and GSK unveils surge in Relenza sales and plans to expand R&D restructuring.
TTP LabTech has launched a contract screening service to assist various aspects of clients’ drug development programmes, from target identification through to preclinical toxicology.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Genzyme strengthening its manufacturing team and Carl Icahn’s representative joining Adventrex’s board.
Pharmadule has teamed up with Morimatsu to capture a share of Chinese pharma and biotech manufacturing markets’ “huge potential.”
Oracle Health Sciences has launched pharmacovigilance software Argus Safety Suite 5.1 to help pharma and CROs meet regulatory compliance and support safety processes from clinical development through post-marketing.
Schott AG has launched its InJentle syringe to improve the stability of highly sensitive drugs, which is a “major topic” for the company’s clients, according to a company director.